Test-retest stability of calibrated BOLD-fMRI in HIV- and HIV+ subjects

NeuroImage

Volumn 54, Issue 3, 2011, Pages 2156-2162

  Ances, Beau ^a   Vaida, Florin ^b   Ellis, Ronald ^c   Buxton, Richard ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood oxygenation level dependent imaging; Cerebral blood flow; Cerebral metabolic rate of oxygen consumption; Functional magnetic resonance imaging; Stability

Indexed keywords

ADULT; ARTICLE; BLOOD OXYGENATION; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN OXYGEN CONSUMPTION; CALIBRATION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERCAPNIA; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MALE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULSE OXIMETRY; VIRUS LOAD;

ADULT; ALGORITHMS; CALIBRATION; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; REPRODUCIBILITY OF RESULTS;

EID: 78650225373     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.09.081     Document Type: Article

References (54)

1. Aguirre G.K., Zarahn E., D'Esposito M. The variability of human, BOLD hemodynamic responses. Neuroimage 1998, 8:360-369.
2. Ances B.M., Roc A.C., Wang J., Korczykowski M., Okawa J., Stern J., Kim J., Wolf R., Lawler K., Kolson D.L., Detre J.A. Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology 2006, 66:862-866.
3. Ances B.M., Leontiev O., Perthen J.E., Liang C., Lansing A.E., Buxton R.B. Regional differences in the coupling of cerebral blood flow and oxygen metabolism changes in response to activation: implications for BOLD-fMRI. Neuroimage 2008, 39:1510-1521.
4. Ances B.M., Liang C.L., Leontiev O., Perthen J.E., Fleisher A.S., Lansing A.E., Buxton R.B. Effects of aging on cerebral blood flow, oxygen metabolism, and blood oxygenation level dependent responses to visual stimulation. Hum. Brain Mapp. 2009, 30:1120-1132.
5. Ances B.M., Sisti D., Vaida F., Liang C.L., Leontiev O., Perthen J.E., Buxton R.B., Benson D., Smith D.M., Little S.J., Richman D.D., Moore D.J., Ellis R.J. Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 2009, 73:702-708.
6. Ances B.M., Vaida F., Yeh M.J., Liang C.L., Buxton R.B., Letendre S., McCutchan J.A., Ellis R.J. HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. J. Infect. Dis. 2010, 201:336-340.
7. Bandettini P.A. What's new in neuroimaging methods?. Ann. NY Acad. Sci. 2009, 1156:260-293.
8. Bartko J.J. The intraclass correlation coefficient as a measure of reliability. Psychol. Rep. 1966, 19:3-11.
9. Bennett C.M., Miller M.B. How reliable are the results from functional magnetic resonance imaging. NY Acad. Sci. 2010, 1191(1):133-155.
10. Boxerman J.L., Hamberg L.M., Rosen B.R., Weisskoff R.M. MR contrast due to intravascular magnetic susceptibility perturbations. Magn. Reson. Med. 1995, 34:555-566.
11. Brown G.G., Eyler Zorrilla L.T., Georgy B., Kindermann S.S., Wong E.C., Buxton R.B. BOLD and perfusion response to finger-thumb apposition after acetazolamide administration: differential relationship to global perfusion. J. Cereb. Blood Flow Metab. 2003, 23:829-837.
12. Brown G.G., Perthen J.E., Liu T.T., Buxton R.B. A primer on functional magnetic resonance imaging. Neuropsychol. Rev. 2007, 17:107-125.
13. Buxton R.B. Interpreting oxygenation-based neuroimaging signals: the importance and the challenge of understanding brain oxygen metabolism. Front Neuroenerg. 2010, 2:8.
14. Buxton R.B., Uludag K., Dubowitz D.J., Liu T.T. Modeling the hemodynamic response to brain activation. Neuroimage 2004, 23(Suppl 1):S220-S233.
15. Carey C.L., Woods S.P., Gonzalez R., Conover E., Marcotte T.D., Grant I., Heaton R.K. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J. Clin. Exp. Neuropsychol. 2004, 26:307-319.
16. Chalela J.A., Alsop D.C., Gonzalez-Atavales J.B., Maldjian J.A., Kasner S.E., Detre J.A. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke 2000, 31:680-687.
17. Chen J.J., Pike G.B. Global cerebral oxidative metabolism during hypercapnia and hypocapnia in humans: implications for BOLD fMRI. J. Cereb. Blood Flow Metab. 2010, 30:1094-1099.
18. Chiarelli P.A., Bulte D.P., Gallichan D., Piechnik S.K., Wise R., Jezzard P. Flow-metabolism coupling in human visual, motor, and supplementary motor areas assessed by magnetic resonance imaging. Magn. Reson. Med. 2007, 57:538-547.
19. Chiarelli P.A., Bulte D.P., Piechnik S., Jezzard P. Sources of systematic bias in hypercapnia-calibrated functional MRI estimation of oxygen metabolism. Neuroimage 2007, 34:35-43.
20. Chiarelli P.A., Bulte D.P., Wise R., Gallichan D., Jezzard P. A calibration method for quantitative BOLD fMRI based on hyperoxia. Neuroimage 2007, 37:808-820.
21. Cicchetti D.V., Sparrow S.A. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am. J. Ment. Defic. 1981, 86:127-137.
22. Davis T.L., Kwong K.K., Weisskoff R.M., Rosen B.R. Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc. Natl Acad. Sci. USA 1998, 95:1834-1839.
23. D'Esposito M., Deouell L.Y., Gazzaley A. Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging. Nat. Rev. Neurosci. 2003, 4:863-872.
24. Eaton K.P., Szaflarski J.P., Altaye M., Ball A.L., Kissela B.M., Banks C., Holland S.K. Reliability of fMRI for studies of language in post-stroke aphasia subjects. Neuroimage 2008, 41:311-322.
25. Ernst T., Itti E., Itti L., Chang L. Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: a coregistered (1)H MRS and SPECT study. J. Magn. Reson. Imaging 2000, 12:859-865.
26. Fernandez G., Specht K., Weis S., Tendolkar I., Reuber M., Fell J., Klaver P., Ruhlmann J., Reul J., Elger C.E. Intrasubject reproducibility of presurgical language lateralization and mapping using fMRI. Neurology 2003, 60:969-975.
27. Fleisher A.S., Podraza K.M., Bangen K.J., Taylor C., Sherzai A., Sidhar K., Liu T.T., Dale A.M., Buxton R.B. Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol. Aging 2009, 30:1737-1748.
28. Goodwin J.A., Vidyasagar R., Balanos G.M., Bulte D., Parkes L.M. Quantitative fMRI using hyperoxia calibration: reproducibility during a cognitive Stroop task. Neuroimage 2009, 47(2):573-580.
29. 2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke 1974, 5:630-639.
30. Hafkenschiel J.H., Friedland C.K., Zintel H.A. The blood flow and oxygen consumption of the brain in patients with essential hypertension before and after adrenalectomy. J. Clin. Invest. 1954, 33:57-62.
31. Jezzard P., Buxton R.B. The clinical potential of functional magnetic resonance imaging. J. Magn. Reson. Imaging 2006, 23:787-793.
32. Jones M., Berwick J., Hewson-Stoate N., Gias C., Mayhew J. The effect of hypercapnia on the neural and hemodynamic responses to somatosensory stimulation. Neuroimage 2005, 27:609-623.
33. Kety S.S., Schmidt C.F. The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men. J. Clin. Invest. 1948, 27:484-492.
34. Kim S.-G., Ugurbil K. Comparison of blood oxygenation and cerebral blood flow effects in fMRI: estimation of relative oxygen consumption change. Magn. Reson. Med. 1997, 38:59-65.
35. Kimberley T.J., Khandekar G., Borich M. fMRI reliability in subjects with stroke. Exp. Brain Res. 2008, 186:183-190.
36. Kliefoth A.B., Grubb R.L., Raichle M.E. Depression of cerebral oxygen utilization by hypercapnia in the rhesus monkey. J. Neurochem. 1979, 32:661-663.
37. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
38. Manoach D.S., Halpern E.F., Kramer T.S., Chang Y., Goff D.C., Rauch S.L., Kennedy D.N., Gollub R.L. Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am. J. Psychiatry 2001, 158:955-958.
39. McGonigle D.J., Howseman A.M., Athwal B.S., Friston K.J., Frackowiak R.S., Holmes A.P. Variability in fMRI: an examination of intersession differences. Neuroimage 2000, 11:708-734.
40. Mintun M.A., Raichle M.E., Martin W.R., Herscovitch P. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J. Nucl. Med. 1984, 25:177-187.
41. Novack P., Shenkin H.A., Bortin L., Goluboff B., Soffe A.M. The effects of carbon dioxide inhalation upon the cerebral blood flow and cerebral oxygen consumption in vascular disease. J. Clin. Invest. 1953, 32:696-702.
42. Pineiro R., Pendlebury S., Johansen-Berg H., Matthews P.M. Altered hemodynamic responses in patients after subcortical stroke measured by functional MRI. Stroke 2002, 33:103-109.
43. Raichle M.E., Mintun M.A. Brain work and brain imaging. Annu. Rev. Neurosci. 2006, 29:449-476.
44. Ramsey N.F., Kirkby B.S., Van Gelderen P., Berman K.F., Duyn J.H., Frank J.A., Mattay V.S., Van Horn J.D., Esposito G., Moonen C.T., Weinberger D.R. Functional mapping of human sensorimotor cortex with 3D BOLD fMRI correlates highly with H2(15)O PET rCBF. J. Cereb. Blood Flow Metab. 1996, 16:755-764.
45. Shrout P.E., Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol. Bull. 1979, 86:420-428.
46. Sicard K.M., Duong T.Q. Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. Neuroimage 2005, 25:850-858.
47. Stefanovic B., Warnking J.M., Kobayashi E., Bagshaw A.P., Hawco C., Dubeau F., Gotman J., Pike G.B. Hemodynamic and metabolic responses to activation, deactivation and epileptic discharges. Neuroimage 2005, 28:205-215.
48. Urs R., Potter E., Barker W., Appel J., Loewenstein D.A., Zhao W., Duara R. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease. J. Comput. Assist. Tomogr. 2009, 33:73-78.
49. Veltman D.J., Friston K.J., Sanders G., Price C.J. Regionally specific sensitivity differences in fMRI and PET: where do they come from?. Neuroimage 2000, 11:575-588.
50. Wang J., Qiu M., Constable R.T. In vivo method for correcting transmit/receive nonuniformities with phased array coils. Magn. Reson. Med. 2005, 53:666-674.
51. Wonderlick J.S., Ziegler D.A., Hosseini-Varnamkhasti P., Locascio J.J., Bakkour A., van der Kouwe A., Triantafyllou C., Corkin S., Dickerson B.C. Reliability of MRI-derived cortical and subcortical morphometric measures: effects of pulse sequence, voxel geometry, and parallel imaging. Neuroimage 2009, 44:1324-1333.
52. Wong E.C., Buxton R.B., Frank L.R. Quantitative perfusion imaging using arterial spin labeling. Neuroimaging Clin. N. Am. 1999, 9:333-342.
53. Zappe A.C., Uludag K., Oeltermann A., Ugurbil K., Logothetis N.K. The influence of moderate hypercapnia on neural activity in the anesthetized nonhuman primate. Cereb. Cortex 2008, 18:2666-2673.
54. Zarahn E., Aguirre G., D'Esposito M. A trial-based experimental design for fMRI. Neuroimage 1997, 6:122-138.